Exousia Bio EBITDA Growth & History (LMMY)
Exousia Bio's calculated EBITDA was −$11,543 for fiscal 2024.
View full Exousia Bio company overviewExousia Bio annual ebitda history
2023
2024
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-05-31 | −$11,543 | $39,845 | — |
| 2023 | 2023-05-31 | −$51,388 | — | — |
Exousia Bio quarterly ebitda
Q2.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-02-28 | −$237,005 | −$243,986 | — |
| Q2 2026 | 2025-11-30 | −$236,437 | −$244,676 | — |
| Q1 2026 | 2025-08-31 | −$31,814 | −$31,148 | — |
| Q3 2025 | 2025-02-28 | $6,981 | $14,418 | — |
| Q2 2025 | 2024-11-30 | $8,239 | $14,429 | — |
| Q1 2025 | 2024-08-31 | −$666 | $10,237 | — |
| Q3 2024 | 2024-02-29 | −$7,437 | −$426 | — |
| Q2 2024 | 2023-11-30 | −$6,190 | $958 | — |
| Q1 2024 | 2023-08-31 | −$10,903 | $809 | — |
| Q4 2023 | 2023-05-31 | −$25,517 | −$24,661 | — |
| Q3 2023 | 2023-02-28 | −$7,011 | — | — |
| Q2 2023 | 2022-11-30 | −$7,148 | — | — |
| Q1 2023 | 2022-08-31 | −$11,712 | — | — |
| Q2 2022 | 2022-05-31 | −$856 | — | — |
Exousia Bio ebitda trends
Between the periods ended 2023-05-31 and 2024-05-31, Exousia Bio's ebitda increased from −$51,388 to −$11,543, a change of $39,845. The latest reported quarter, Q3 2026, shows −$237,005.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Exousia Bio source filings ↗